Abdera Therapeutics
↗South San Francisco, USA / Vancouver, Canada
Abdera Therapeutics is a clinical-stage biopharmaceutical company focused on developing precision radiopharmaceuticals for cancer. The company utilizes its proprietary Radio Optimized Vector Engineering (ROVEr™) platform to engineer antibody-based therapies that deliver potent radioisotopes (such as Actinium-225) to solid tumors, aiming to maximize therapeutic effect while minimizing systemic toxicity.
Headquartered in South San Francisco, California, with additional offices in Vancouver, British Columbia, Abdera is backed by venture capital and is actively advancing a pipeline of targeted alpha therapies. Its lead program, ABD-147, is currently in clinical development for small cell lung cancer and large cell neuroendocrine carcinoma.
CLASSIFICATION
SIZE & FINANCIALS
Employees:51-200
Founded:2020
Ownership:private
Status:operating
FUNDING
Stage:Series B
Total Raised:$142M
Investors:Versant Ventures, AbCellera, adMare BioInnovations, Foresite Capital, venBio
PIPELINE
Stage:Phase 1
Lead Drug Stage:Phase 1
Modalities:Radiopharmaceuticals, Antibody engineering
Active Trials:1
Trial Phases:Phase 1: 1
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Key Partnerships:AbCellera (Founding partner, antibody discovery platform)
COMPETITION
Position:Emerging
Competitors:Novartis, RayzeBio, Point Biopharma, Bayer, Alpha-9 Oncology
LEADERSHIP
Key Executives:
Lori Lyons-Williams - President & CEO
Rachael Brake - Chief Scientific Officer
Philippe Bishop - Chief Medical Officer
Scientific Founders:Lana Janes, Michael Abrams
Board Members:Eric Dobmeier
LINKS
Website:abderatx.com
LinkedIn:LinkedIn Profile
⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of Abdera Therapeutics and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Abdera Therapeutics. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.